The binding of tumor PD-L1 with the receptor PD-1 on T cells activates a signaling cascade that alters the T cell activity in many ways, including the inhibition of T cell proliferation and survival, cytokine production and other effector functions [36]. The gene discussed is CD274; the disease is neoplasm.